⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated cost per beneficiary
Risk indicators are statistical patterns, not allegations. Learn more
729
Total Claims
$842K
Drug Cost
102
Beneficiaries
$8,256
Cost/Patient
Risk Score Breakdown 3/100
Low (0)Moderate (15)Elevated (30)High (50+)
Cost per patient outlier+3
Score components are additive. Read full methodology
Peer Comparison vs. 6,382 Endocrinology providers
+110%
Cost per patient vs peers
$8,256 vs $3,933 avg
+60%
Brand preference vs peers
81.6% vs 51.2% avg
Brand vs Generic
18% generic
Brand: 480 claims · $773K
Generic: 108 claims · $2,946
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 71 | $145K |
| Semaglutide | 84 | $118K |
| Empagliflozin | 53 | $89K |
| Insulin Aspart | 28 | $66K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $56K |
| Insulin Lispro | 25 | $51K |
| Insulin Pump Cart,automated,bt | 28 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $29K |
| Insulin Aspart | 23 | $28K |
| Insulin Lispro | 19 | $23K |
| Alcohol Antiseptic Pads | 20 | $2,686 |
| Pen Needle, Diabetic | 13 | $2,477 |
| Levothyroxine Sodium | 13 | $1,211 |
| Metformin Hcl | 21 | $504 |
| Metformin Hcl | 18 | $318 |
Prescribing Profile
Patient Profile
65
Avg Age
53%
Female
2.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About